Name: UMIN ID:
Unique ID issued by UMIN | UMIN000006877 |
---|---|
Receipt number | R000008105 |
Scientific Title | Phase II study of XELIRI with bevacizumab as second-line therapy for metastatic colorectal cancer -Beyond Progression Disease of capecitabine and bebacizumab - |
Date of disclosure of the study information | 2011/12/12 |
Last modified on | 2020/07/28 11:20:42 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/12/12 14:50:02 | ||
2 | Update | 2013/12/12 14:42:44 | TEL |
|
3 | Update | 2014/06/13 14:33:58 | Email |
|
4 | Update | 2015/08/12 14:37:26 | Recruitment status |
|
5 | Update | 2020/07/28 11:20:42 | Recruitment status Date of IRB Last follow-up date |